Around 22 thousand people have been immunized as part of Phase III of the clinical trial of the Soberana 02 vaccine candidate, almost half of the population foreseen in that study, said Vicente Vérez Bencomo, general director of the Finlay Vaccine Institute (IFV).

The Cuban COVID-19 candidate vaccines are a symbol of hard work of the island’s scientists, said Health Minister Jose Angel Miranda.

The just-born diagnosed with COVID-19 in Cuba have been infected by their fathers who live with them or visit them at home, and not by a mother-to-fetus transmission, said an expert in the field.

Cuba studied 18,162 samples for COVID 19, resulting in 774 positive ones. The country accumulates 2,825,292 samples taken and 68,250 positive.

HAVANA, Cuba, Mar 23 (ACN) In addition to the measures that can be taken to control COVID-19, people's self-responsibility must continue increasing, said today in Havana Dr. Francisco Duran, national director of Epidemiology of the Cuban Ministry of Public Health.

In addition to the measures that can be taken to control COVID-19, people's self-responsibility must continue increasing, said today in Havana Dr. Francisco Duran, national director of Epidemiology of the Cuban Ministry of Public Health.

With the application of the immunogen to 250 university students, phase III of the clinical trial of CIGB-66 (Abdala), one of the five nationally produced anti-COVID-19 vaccine candidates, began on Monday in Santiago de Cuba.

Villa Clara continues to be the oldest province in Cuba, according to records by the end of last year, with 25 % of its population made up of people aged 60 years or older, followed by Havana and Sancti Spiritus.

Carlos Perez Diaz, who was head of the Cuban medical mission in Lombardy, Italy, sent a greeting to the people of Crema, on the one-year anniversary of the arrival in that European nation of a group of specialists from the Henry Reeve contingent, to combat the COVID-19 pandemic.

Cuba studied 18,966 samples for COVID 19, resulting in 718 positive ones. The country accumulates 2,807,130 samples taken and 67,476 positive.

Havana, March 19 (ACN) A third medical brigade with the Cuban International Contingent specialized in disaster situations and serious epidemics is on its way to Qatar to support that nation against the COVID-19 pandemic.

The Cuban COVID -19 candidate vaccine named ABDALA is entering phase III trials March 22 to April 9 in the eastern cities of Santiago de Cuba and Guantanamo.

Cuba studied 19,537 samples for COVID 19, resulting in 689 positive ones. The country accumulates 2,730,305 samples taken and 64,414 positive.

In a year of confronting the COVID-19 pandemic, students of the Universities of Medical Sciences throughout the country have played an important role, based on the concept of learning from work, which contributes positively to their academic training.